Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors

Clinical Genitourinary Cancer(2023)

引用 0|浏览10
暂无评分
摘要
BMI was not associated with survival or response rates of advanced RCC or UC patients treated with ICIs in an Asian population. AEs might frequently develop in high-BMI patients with RCC in nivolumab monotherapy.
更多
查看译文
关键词
Avelumab,Axitinib,Obesity,Ipilimumab,Nivolumab,Pembrolizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要